Skip to content
NutraIngredients NutraCast cover art

All episodes

NutraIngredients NutraCast, 347 episodes. Page 4 of 4.

#
Title
301

Nestlé enters functional foods ring as claims climate heats up

302

Snack Size Science: Cranberry’s promise for prostates

303

AHPA president: nothing to fear from AER

304

Fast-C stakes claim to vitamin C bioavailability crown

305

Omega-3: from academia to commercial blockbuster

306

Omega-3 industry ups ante on Proposition 65 legal action

307

The medicine hunter: ‘I help to establish trade in plants’

308

Expo West reflections: post-recession buy-outs and GMP compliance

309

NPA chief: Industry must remain vigilant after McCain Bill victory

310

McCain ‘flip-flops’ on supplements reform Bill

311

The promise of evolving resveratrol science

312

Too many trade groups spoil the lobbying broth?

313

Blumenthal: On supplements regulations and outrunners

314

DSHEA turns 15 and growing up fast

315

Pontiakos: FDA is doing a fine job

316

Omega-3 welcomes big fish into fold

317

Obama bill unlikely to alter medical stance on supplements

318

The untold success stories of vitamins

319

Biomarkers may hold the key for nutrition and health claims

320

The healthy immune health market

321

AERs reflect supplement usage patterns, says AHPA

322

Antioxidant methods vital for ensuring health benefits: Expert

323

Probiotic guidance that industry’s ‘been waiting for’

324

Functional market won’t wait for procrastinators, says analyst

325

Grand plans for vitamins

326

Market expected to rebound from Hydroxycut blow

327

Euromonitor breaks down functional foods and supplements market

328

How the EU health claims process could impact US

329

Immunity claims are next on FTC’s radar, says legal expert

330

Fierce clamp-down for swine flu supplements

331

GMP inspections likely to start by fall, says FDA

332

Banker: nutraceuticals stay hot amid economic freeze

333

Playing ball in China's health claims park

334

Supply Side East preview

335

Why omega-3 nutrient claims are important, GOED

336

Reading between the omega-3 aisles at Expo West

337

CRN: GMP blind spots remain

338

Israelsen: 'You wouldn’t know there is a recession'

339

FDA: we will enforce GMPs

340

What NutraIngredients-USA took away from Expo West

341

GOED prepares petition for omega-3 RDA

342

Approaching Expo West

343

Petitions: The new tool to attack supplements

344

The biggest challenges in making GMPs work

345

Supplements, functional foods and the era of tighter regulations

346

Exploring the sweet future for stevia

347

What is Section 912?

348

What NutraIngredients-USA took away from SSW